Acne and acne scars share a name and very little else from a procedural standpoint.
Active acne is an inflammatory skin disease. Acne scars are structural changes left after inflammation and healing. A laser designed to influence sebaceous glands is not doing the same job as fractional CO₂ resurfacing. A red-light acne device is not a scar treatment. RF microneedling used for scars is not automatically the answer to active cystic breakouts.
If a treatment menu puts all of this under “acne laser,” make it get more specific.
Where the choice actually differs
Two problems that share a name| On | Active acne | Acne scars |
|---|---|---|
| What it actually is | An inflammatory skin disease | Structural change left behind after inflammation and healing |
| What the procedure is for | Changing the disease process | Remodeling what the healing left |
| What gets targeted | C. acnes-related pathways, inflammation, vascular components, sebaceous glands | Scar architecture — ice-pick, rolling, boxcar, raised, keloid |
| Devices in play | Blue and red visible light, photodynamic therapy, IPL, PDL, infrared and 1726-nm lasers | Fractional CO2, subcision, focal techniques |
| Realistic result | Can reduce acne for some people, and usually does not clear it alone | Improvement, limited by how much deep tethering the surface can reach |
| Where it sits in the order | First | After the acne is controlled |
What changes the answer: Many people have more than one scar type at once, which is why a scar plan usually combines procedures instead of picking a device.
What an acne device is actually trying to change
Every light and laser approach to active acne aims at one of four things: Cutibacterium acnes-related pathways, inflammation, vascular components, or the sebaceous glands. Blue and red visible light, photodynamic therapy, IPL, PDL, infrared lasers and the newer 1726-nm systems distribute themselves across those four targets. A clinic that cannot say which target it has bought into has not made a clinical choice, it has made a purchase.
The American Academy of Dermatology notes that light and laser treatments can reduce acne for some patients but usually do not clear acne by themselves. Different devices target different lesion types, and combination treatment remains common. That is the honest ceiling: a contribution, not a cure.
1726-nm acne lasers are one of the more interesting newer categories
The 1726-nm wavelength is designed around selective heating of sebaceous glands. That makes the mechanism different from the older consumer idea of “blue light kills acne bacteria.”
Research on 1726-nm systems has expanded quickly. A 2026 systematic review examined efficacy and adverse events of laser treatments for acne across diverse skin types, and two-year real-world outcomes for a 1726-nm platform were published in July 2026. This is a category worth watching because it targets a biologically relevant structure and has growing follow-up data.
It is still not permission to convert “FDA cleared” into “best acne treatment for everyone.” Acne phenotype, severity, medication history, scarring risk, skin tone, cost and the strength of comparative evidence all matter.
Photodynamic therapy is more treatment than “blue light facial”
Photodynamic therapy is a genuine medical-aesthetic treatment category, not a spa add-on to be sold as extra glow while we are here. It combines a photosensitizing agent with light activation, and depending on the protocol it can produce meaningful inflammation, photosensitivity and recovery requirements. The AAD specifically notes that after some forms of PDT patients must avoid sunlight for a defined period.
A 2025 systematic review of PDT for acne included thousands of participants across dozens of studies and found clinically relevant benefit, but the literature remains heterogeneous in sensitizers, light sources, protocols and outcome measures. Which means the benefit is real and the specific protocol you are being offered may not be the one that produced it. Ask which sensitizer, which light source, how long.
With scars, the shape comes before the machine
Once acne is controlled, the procedural question changes from stopping lesions to remodeling scars. And the first thing to establish is not what the clinic owns. It is what shape the scars are.
Ice-pick, rolling, boxcar, raised and keloid scars each want a different approach, and the AAD says so plainly. A rolling scar tethered by fibrous bands may need subcision. Deep ice-pick scars may respond to focal techniques. Broader boxcar or textural scarring may benefit from fractional resurfacing. Raised scars require an entirely different strategy. Most faces carry several of these at once, which is why good scar plans look like a sequence of procedures rather than a single purchase — the full sorting is in the acne-scar treatment map.
Fractional CO₂ can remodel scars; it cannot untether everything
Fractional CO₂ remains one of the strongest-established laser options for atrophic acne scarring, but a laser can only remodel what its mechanism can reach. Deep tethering may limit how much surface resurfacing can accomplish on its own.
Recent meta-analyses continue to show that ablative fractional approaches can produce meaningful scar improvement, with a larger downtime and adverse-effect burden than many nonablative options. So the practical question is not “Does CO₂ work?” It is “What portion of my scar pattern is CO₂ expected to change, and what will still be there afterwards?” Make somebody answer the second half.
RF microneedling is a scar option with a newly louder risk conversation
A 2025 systematic review of fractional RF microneedling for acne scars included 16 studies and 481 patients and concluded that the treatment is likely effective as monotherapy, while calling for better randomized trials to establish parameters.
That evidence now sits beside the FDA’s October 2025 safety communication over serious complications reported with certain uses of RF microneedling: burns, scarring, fat loss, disfigurement and nerve damage. Evidence of benefit and a live safety signal are not opposites. They are the two halves of a consent conversation, and most clinics hold only one of them.
Microneedling without RF remains relevant
Conventional microneedling induces controlled mechanical injury and collagen remodeling without adding RF energy, and the AAD notes it can be used across skin tones and may be combined with other scar treatments. For some people that is simply a better trade on cost, downtime and pigment risk. More technology is not the same thing as a better scar plan.
Scar color and scar depth are different treatment problems
Red post-acne marks, brown PIH and true depressed scars can coexist. Treating them as one “scar” problem encourages confusion.
- Redness: may involve vascular-targeted approaches in selected cases.
- Brown PIH: pigment management and sun protection; energy treatment requires caution.
- Depressed scars: structural remodeling, subcision, resurfacing, needling, fillers or combinations.
- Raised scars/keloids: a different treatment family entirely.
A perfect laser for redness will not lift a tethered rolling scar. A fractional resurfacing laser may improve texture without erasing residual pigment — and if the pigment is the part that bothers you most, it needs its own diagnosis before anyone picks a wavelength.
Control active acne before polishing the evidence of old acne
The AAD advises that active breakouts are generally treated before scar procedures so new inflammation is not continuing to create scars during the correction process.
This is also where acne lasers should be judged against ordinary acne treatment. “Better than doing nothing” is too weak a comparator for a treatment decision. A device may be useful for someone who cannot tolerate, does not respond to, or wants to reduce reliance on certain conventional options. That is different from claiming technology should automatically replace topical or systemic treatment.
Questions that force the plan to separate acne from scars
- Are we treating active acne, redness/pigment, scars, or more than one of these?
- If active acne: what lesion type or biological target is this device intended to affect?
- If scars: which scar types do I have?
- Does any tethering need subcision or another procedure before resurfacing?
- Why this device rather than conventional microneedling, fractional laser, RF microneedling, medication or another option?
- How does my skin tone change pigment risk?
- What improvement is realistic after the full course?
- What is the plan to prevent new acne scars while treating old ones?
Two jobs, one word
“Acne laser” is an inadequate category.
Active acne treatment is trying to change an ongoing disease process. Acne-scar treatment is trying to remodel the architecture left behind. The same person may need both at different times, but the goals, evidence and device logic should never be blurred into one package — and the package is precisely where they get blurred.
Evidence check: Moderate
Evidence level: moderate and modality-dependent for laser/light treatment of active acne; moderate to strong for selected procedural treatment of acne scars, with multimodal care often required.
Sources reviewed August 8, 2026:
- American Academy of Dermatology: Lasers and Lights for Acne.
- American Academy of Dermatology: Acne Scar Treatment.
- 2026 systematic review of laser treatments for acne vulgaris in diverse skin types.
- 2026 two-year real-world outcomes of a 1726-nm acne laser.
- 2025 systematic review of RF microneedling for acne scars.
- FDA: RF Microneedling Safety Communication.
This is general education and does not replace diagnosis or individualized acne treatment.
